Skip to content

Total Revenue at other companies

Eli Lilly logo
Eli LillyLLY
$19.8B+55.5%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$24.06B+9.9%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$1.07B+19.1%
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
$191.2M+57.4%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$814.5M+42.2%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$194.52M+66.8%

Other financials

Income statement

See full
Operating income-$112.3M-54.4%
Net income-$102.3M-57.3%
EPS (diluted)-$1.17-41.0%

Balance sheet

See full
Cash & equivalents$545.9M+368%
Total debt$7.5M-13.6%
Total equity$1.3B+90.0%
Total assets$1.4B+86.6%

Cash flow

See full
Operating cash flow-$88.9M-44.2%
CapEx$133.0K+209%
Free cash flow-$89.0M-44.3%

Valuation

See full
Market cap$5.11B+116%
Enterprise value$4.58B+104%

Profitability

See full
Operating margin-4,974.3%
Net margin-4,612.1%
FCF margin-3,732.2%

Returns & leverage

See full
Return on equity-37.5%+8.7pp
Debt / equity0.0×
Current ratio27.8×+10.1×

Where this comes from

Reported directly by Xenon Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.

The official record: Xenon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Xenon Pharmaceuticals's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Xenon Pharmaceuticals's total revenue?
Xenon Pharmaceuticals (XENE) reported total revenue of $0 in Q1 2026.
How has Xenon Pharmaceuticals's total revenue changed year-over-year?
Xenon Pharmaceuticals's total revenue decreased by 100.0% year-over-year, from $7.5M to $0.
What is the long-term trend for Xenon Pharmaceuticals's total revenue?
Over 4 years (2021 to 2025), Xenon Pharmaceuticals's total revenue has grown at a -20.1% compound annual growth rate (CAGR), from $18.44M to $7.5M.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.